ConcR
concr.coLocations
Cambridge, UK
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Seed
founded in
2018
Concr combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. Concr aims to: • Reduce treatment resistance • Cut the cost of cancer treatment • Enable proactive treatment adaptation • Save lives
Something looks off?Open jobs at ConcR